If the basket trial shows effect of Leronlimab on other cancers, as soon as Leronlimab is approved for combo for HIV-1, its use off-label for cancers could explode. CYDY should not talk about it, but the order of activities goes in that direction. Not to mention that in this case, after a few weeks, we know if Leronlimab works, because otherwise it all takes a very long time, these are incredible things.